Data from the Korean Health Insurance Review and Assessment Service showed that “the number of patients with hearing loss increased by 30% to 418,092 in 2019 from 293,620 in 2015,” and “Korea Biomedical Review” reports that some otolaryngologists have reported an increase in patients seeking hearing tests.
A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.
Said to be “wireless and lightweight,” OrCam MyEye is an “advanced wearable assistive technology” for people who are blind or visually impaired. The finger-sized device helps provide access to visual information—communicated by audio—hands-free, as the device attaches to any pair of eyeglasses.
Managing a hearing care practice has never been more challenging than during the Covid-19 pandemic. Practice management expert and industry veteran Dan Quall, MS, provides tips for managing cash-flow, revenue generation and patient care, and how to prepare your practice for emerging from this crisis stronger than ever.
Chester Pirzanski, a long-time expert in earmold impression and manufacturing, proposes a new invention and automated process for designing custom hearing aid shells and earmolds from digitized ear impressions.
“The Minneapolis Star-Tribune” reports that over 200,000 people have joined a mass tort against 3M, alleging that Aearo’s Combat Arms earplugs “were knowingly defective, imperceptibly loosening and leaking in noise.” The Combat earplugs were acquired by 3M as part of its $1.2 billion purchase of Aearo Technologies in 2008.